ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,520Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 34

$1.81M Total Retail Price of All Prescriptions

Rank: 1 out of 34

505 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,773 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 48%.

Prescription Price

$134 was the average price of a prescription from this provider, compared to $139 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
CRESTOR 910 469 1 14
SYNTHROID 633 424 2 2
GLIMEPIRIDE 469 301 3 6
INSULIN SYRINGE 463 227 4 9
LEVOTHYROXINE SODIUM 436 237 5 1
HUMULIN N 413 238 10 6 25
METFORMIN HCL 408 155 7 3
FUROSEMIDE 360 231 8 20
JANUVIA 350 256 9 11
FENOFIBRATE 345 219 10 22
ENALAPRIL MALEATE 331 195 11 33
ACTOS 330 204 12 21
NOVOLIN N 323 170 13 35
PEN NEEDLE 298 155 14 4
SIMVASTATIN 264 194 15 8
AMLODIPINE BESYLATE 258 184 16 19
LOSARTAN POTASSIUM 246 159 17 34
ZETIA 240 111 18 24
NOVOLOG 236 100 19 12
NIASPAN 234 92 20 46
HUMALOG 229 121 21 16
LISINOPRIL 229 147 21 13
PRAVASTATIN SODIUM 219 144 23 26
GABAPENTIN 206 72 24 29
TRICOR 192 55 25 50
METOPROLOL SUCCINATE 191 129 26 31
LANTUS SOLOSTAR 186 93 27 5
LOVAZA 182 74 28 51
ATORVASTATIN CALCIUM 180 125 29 15
HYDROCHLOROTHIAZIDE 174 124 30 36
ALENDRONATE SODIUM 159 125 31 23
PIOGLITAZONE HCL 143 94 R 32 48
LANTUS 121 46 33 7
METOPROLOL TARTRATE 110 80 34 27
CARVEDILOL 109 69 35 53
NOVOLOG FLEXPEN 103 50 36 10
LOSARTAN-HYDROCHLOROTHIAZIDE 96 62 37 79
VITAMIN D2 94 65 38 57
ATENOLOL 91 65 39 43
METHIMAZOLE 90 76 40 30
CYMBALTA 82 36 41 82
ACTONEL 69 68 42 90
RAMIPRIL 69 14 42 69
SPIRONOLACTONE 68 29 44 73
METFORMIN HCL ER 66 22 45 18
EVISTA 64 52 46 96
CLONIDINE HCL 64 28 46 96
TRILIPIX 63 16 48 73
POTASSIUM CHLORIDE 63 38 48 41
TRAMADOL HCL 58 19 50 61
WELCHOL 56 35 51 105
NEXIUM 54 23 52 40
LYRICA 52 14 53 113
OMEPRAZOLE 51 32 54 28
AMLODIPINE BESYLATE-BENAZEPRIL 51 19 54 115
CALCITRIOL 50 49 56 70
ONGLYZA 50 46 56 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.